id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-316626-258rbcwb	Serpa Neto, Ary	Will Evidence-based Medicine Survive the COVID-19 Pandemic?	2020-09-17		.txt	text/plain	1459	50	34	Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state Observational study of hydroxychloroquine in hospitalized patients with Covid-19 Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial Arguing for adaptive clinical trials in sepsis Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop Using Bayesian adaptive designs to improve phase III trials: a respiratory care example ORCHID Protocol Committee and the National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Network Investigators. One major challenge during the pandemic is to design clinical trials that can mitigate these concerns and quickly identify effective or harmful interventions to improve patient outcomes.	cache/cord-316626-258rbcwb.txt	txt/cord-316626-258rbcwb.txt
